CAMARILLO, Calif., June 25, 2007 (PRIME NEWSWIRE) -- IntegrityBio, LLC (formerly known as Integrity Biosolution), a research formulation and contract manufacturing provider, announced at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, the opening of its Good Manufacturing Practices (GMP) fill and finish facility for the contract manufacturing of infusion- or injection-based products that are preclinical or entering Phase I and Phase II clinical trials for the biotechnology and pharmaceutical industries. The facility has the capacity to accommodate the manufacturing of up to 10,000 liquid formulation vials or 3,000 of lyophilized formulation vials per lot.
